Restoration of mRNA Expression of Solute Carrier Proteins in Liver of Diet-Induced Obese Mice by Metformin
Metformin (MET), the most common medicine for type 2 diabetes (T2DM), improves insulin sensitivity by targeting the liver, intestine and other organs. Its impact on expression of the solute carrier (Slc) transporter genes have not been reported in the mechanism of insulin sensitization. In this stud...
Main Authors: | Jiamei Le, Yi Fu, Qiuqin Han, Xindong Wei, Houlin Ji, Yifan Chen, Qiuying Wang, Peixian Pi, Jilei Li, Xinjie Lin, Xiaoying Zhang, Yong Zhang, Jianping Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.720784/full |
Similar Items
-
Transcriptome Analysis of the Inhibitory Effect of Sennoside A on the Metastasis of Hepatocellular Carcinoma Cells
by: Jiamei Le, et al.
Published: (2021-01-01) -
Metformin, Macrophage Dysfunction and Atherosclerosis
by: Xiaojun Feng, et al.
Published: (2021-06-01) -
Metformin as a potential protective therapy against tuberculosis in patients with diabetes mellitus: A retrospective cohort study in a single teaching hospital
by: Chia‐Po Fu, et al.
Published: (2021-09-01) -
Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes
by: Wei Chen, et al.
Published: (2016-11-01) -
Metformin extends C. elegans lifespan through lysosomal pathway
by: Jie Chen, et al.
Published: (2017-10-01)